Tata Chemicals Q1 Review - Revival In End User Demand To Drive Growth: ICICI Direct
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Tata Chemicals Ltd.'s Q1 FY22 topline was marginally above but margins beat primarily due to lower-than-expected power and fuel and freight cost.
Reported revenue growth of 26.8% YoY to Rs 2977.2 crore, led by higher growth in the basic chemical segment across four units.
Gross margins expanded 330 basis points YoY to ~78.1% while Ebitda margin improved 490 bps YoY to 20.2 due to operating leverage.
Ebitda was up 67% YoY to Rs 601.2 crore.
Profit after tax was at Rs 288 crore against Rs 13.3 crore in Q1 FY21.
Tata Chemicals' growth was largely due to strong operational performance and higher share from joint venture.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.